Healthcare Global Enterprises Limited (HCG) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.193x

Based on the latest financial reports, Healthcare Global Enterprises Limited (HCG) has a cash flow conversion efficiency ratio of 0.193x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.92 Billion ≈ $20.79 Million USD) by net assets (Rs9.94 Billion ≈ $107.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Healthcare Global Enterprises Limited (HCG) balance sheet quality index to measure how much of total assets are equity-financed.

Healthcare Global Enterprises Limited - Cash Flow Conversion Efficiency Trend (2011–2026)

This chart illustrates how Healthcare Global Enterprises Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Healthcare Global Enterprises Limited's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Healthcare Global Enterprises Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Healthcare Global Enterprises Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Wuxi Dk Electronic Materials Co Ltd
SHE:300842
0.288x
BKI Investment Company Ltd
AU:BKI
0.025x
Manchester United Ltd
F:MUF
-0.060x
Petkim Petrokimya Holding AS
IS:PETKM
0.034x
North Huajin Chemical Industries Co Ltd
SHE:000059
-0.073x
Zhejiang Fulai New Material Co.Ltd.
SHG:605488
0.025x
Instalco Intressenter AB
ST:INSTAL
0.133x
CONMED Corporation
NYSE:CNMD
0.013x

Annual Cash Flow Conversion Efficiency for Healthcare Global Enterprises Limited (2011–2026)

The table below shows the annual cash flow conversion efficiency of Healthcare Global Enterprises Limited from 2011 to 2026. For the full company profile with market capitalisation and key ratios, see market cap of Healthcare Global Enterprises Limited.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs14.10 Billion
≈ $152.51 Million
Rs3.47 Billion
≈ $37.54 Million
0.246x -23.15%
2025-03-31 Rs9.90 Billion
≈ $107.07 Million
Rs3.17 Billion
≈ $34.29 Million
0.320x -2.63%
2024-03-31 Rs8.65 Billion
≈ $93.56 Million
Rs2.85 Billion
≈ $30.78 Million
0.329x +13.67%
2023-03-31 Rs8.69 Billion
≈ $94.02 Million
Rs2.52 Billion
≈ $27.21 Million
0.289x +16.17%
2022-03-31 Rs8.84 Billion
≈ $95.57 Million
Rs2.20 Billion
≈ $23.81 Million
0.249x +47.57%
2021-03-31 Rs7.14 Billion
≈ $77.22 Million
Rs1.21 Billion
≈ $13.03 Million
0.169x -45.55%
2020-03-31 Rs4.20 Billion
≈ $45.40 Million
Rs1.30 Billion
≈ $14.07 Million
0.310x +64.35%
2019-03-31 Rs5.22 Billion
≈ $56.47 Million
Rs985.04 Million
≈ $10.65 Million
0.189x +11.67%
2018-03-31 Rs5.79 Billion
≈ $62.62 Million
Rs978.13 Million
≈ $10.58 Million
0.169x -9.29%
2017-03-31 Rs4.90 Billion
≈ $53.00 Million
Rs912.79 Million
≈ $9.87 Million
0.186x +16.66%
2016-03-31 Rs4.59 Billion
≈ $49.59 Million
Rs731.97 Million
≈ $7.92 Million
0.160x -44.47%
2015-03-31 Rs2.08 Billion
≈ $22.44 Million
Rs596.53 Million
≈ $6.45 Million
0.287x +57.70%
2014-03-31 Rs2.82 Billion
≈ $30.51 Million
Rs514.22 Million
≈ $5.56 Million
0.182x +73.35%
2013-03-31 Rs2.96 Billion
≈ $32.01 Million
Rs311.26 Million
≈ $3.37 Million
0.105x +4206.51%
2012-03-31 Rs2.19 Billion
≈ $23.73 Million
Rs-5.62 Million
≈ $-60.78K
-0.003x -102.04%
2011-03-31 Rs1.76 Billion
≈ $19.08 Million
Rs221.98 Million
≈ $2.40 Million
0.126x --

About Healthcare Global Enterprises Limited

NSE:HCG India Medical Care Facilities
Market Cap
$1.08 Billion
Rs100.21 Billion INR
Market Cap Rank
#8425 Global
#427 in India
Share Price
Rs671.20
Change (1 day)
+0.23%
52-Week Range
Rs521.75 - Rs776.30
All Time High
Rs776.30
About

HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. The company offers cancer diagnostics services, including genomics and molecular diagnostics, digital PET, preventive oncology, physical examination, laboratory tests, home health services, digital pathology, and CTC detection; treatment services, such as medical oncology and haemato-oncol… Read more